Used in pharmaceutical research as a potent and selective inhibitor of soluble epoxide hydrolase (sEH), this compound is investigated for its anti-inflammatory and analgesic properties. It shows potential in treating neuropathic pain and inflammatory conditions by modulating epoxy fatty acid metabolism. Due to its ability to cross the blood-brain barrier, it is also explored for central nervous system disorders. Its structural features enhance metabolic stability and target engagement, making it a valuable tool compound in preclinical studies focused on pain management and inflammation-related diseases.